+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain Drug"

Neuropathic Pain Market Report 2025 - Product Thumbnail Image

Neuropathic Pain Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Chronic Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Peripheral Neuropathic Pain-Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain-Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Neuropathic Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peripheral Neuropathic Pain Pipeline Analysis Report 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
Postherpetic Neuralgia (PHN) Global Market Report 2025 - Product Thumbnail Image

Postherpetic Neuralgia (PHN) Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Paresthesia Treatment - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 381 Pages
  • Global
From
Pregabalin - Global Strategic Business Report - Product Thumbnail Image

Pregabalin - Global Strategic Business Report

  • Report
  • August 2025
  • 372 Pages
  • Global
From
Diabetic Neuropathic Pain - Global Strategic Business Report - Product Thumbnail Image

Diabetic Neuropathic Pain - Global Strategic Business Report

  • Report
  • August 2025
  • 384 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 276 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 898 Pages
  • Global
From
From
From
Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 3092 Pages
  • Global
From
Loading Indicator

The Neuropathic Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathic pain drugs are used to treat chronic pain caused by nerve damage, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. These drugs are typically divided into two categories: anticonvulsants and antidepressants. Anticonvulsants are used to reduce the intensity of nerve pain, while antidepressants are used to reduce the frequency of nerve pain. Commonly prescribed neuropathic pain drugs include pregabalin, gabapentin, duloxetine, and amitriptyline. Some companies in the Neuropathic Pain Drug market include Pfizer, GlaxoSmithKline, Eli Lilly, and Novartis. Show Less Read more